Emerging evidence suggests that the there are several different mechanisms involved in the regulation of FOXK2 activity in cancer cell, such as hypermethylation, noncoding RNAs (ncRNAs), and post-translational modifications (PTMs). The gene discussed is FOXK2; the disease is cancer.